Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patients easlfibronostg on June 26, 2026 Category: Publications Tag: Diabetes, LIVERFASt, MASLD, Monitoring, NAFLD Post navigation Previous: Previous post: Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements (regression poster)Next: Next post: Long-term prognosis of MAFLD patients according to non-invasive methods
